The partnership happened after Lumbry Park’s Clinical Director, veterinary cardiologist, Dr Luca Ferasin and his wife Heidi had a son, Mattia, with multiple and life-threatening congenital heart defects. During their son's subsequent treatment, which involved seven hours of successful open heart surgery, Dr Ferasin and his wife got to know Dr Caner Salih, a consultant paediatric cardiac surgeon and member of the team caring for Mattia. So when Dr Salih acquired French Bulldog puppy called Büdu a few weeks later, and a heart murmur was detected during his first visit to the vet, he turned to Dr Ferasin for advice.
Dr Ferasin diagnosed Büdu with the congenital heart condition Perimembranous Ventricular Septal Defect (VSD). A VSD is characterised by a hole between the left and right ventricles of the heart which causes an abnormal blood flow between the two chambers. Ironically, a large VSD was one of the multiple heart defects successfully corrected during Mattia’s life-saving cardiac surgery.
Dr Salih said: "I first met Dr Ferasin and Heidi under one of the most stressful circumstances a parent can experience, that of waiting for a child to undergo life-saving cardiac surgery. Sometime later I had first-hand experience of something not comparable but nonetheless very stressful of having to wait for the results of a diagnostic test which Dr Ferasin was able to provide for our newly acquired puppy. I appreciated more than ever the importance of knowing that our newest family member was in the most capable of hands."
Dr Ferasin said: "The related stories of Mattia and Büdu highlight the remarkable similarities between paediatric and small animal medicine, not only in terms of medical conditions, diagnostic techniques and therapeutic procedures, but also in terms of the psychological, emotional and social importance of the human-animal bond – in both directions. After all, just like babies and young children, veterinary patients cannot communicate with us - while their ‘parents’ have the same need for reassurance that their beloved ‘baby’ will recover.
"Our partnership with the Evelina London Children’s Hospital will celebrate these similarities and promote the concept of ‘One Health’ in a bid to advance both human and veterinary medicine. By working closely with the Evelina London, we aim to contribute positively to the development of novel techniques, research and therapies in both our children and in companion animals. We’re planning a range of initiatives, including fundraising and collaborations with the clinical staff at Lumbry Park and the Evelina London, in particular with those in the cardiology and cardiac surgery departments. We’re also planning social events, such as advanced pet-therapy sessions for children undergoing treatment at the Evelina and their families, including direct interaction with our veterinary patients with similar conditions."
He added: "Thanks to the dedicated team at the Evelina London Children’s Hospital, Mattia is thriving and is a happy, healthy and fun-loving little boy. He will continue to visit the hospital for reassessments as he grows. Büdu visited us again at Lumbry Park during 2016 for a reassessment and an ultrasound of his heart showed the spontaneous closure of his VSD, resulting in the resolution of his condition. This is a rare but fantastic outcome which, to the best of our knowledge, has only been reported in a couple of canine cases in the veterinary literature. What better reason to cement the bond between human and veterinary medicine!"
Dr Salih added: "Many people do not appreciate the amount of shared learning that has, for decades, occurred between the study of animals and medicine. Many of the advances in areas of human healthcare we embrace today simply could not exist without this relationship – and open heart surgery is one. The Evelina is delighted to be collaborating with Lumbry Park on this exciting venture."
Eilona's is one of 50 new jobs created by the company in the last 12 months alone, across a range of positions including veterinary surgeons, nurses and client care co-ordinators.
Eilona said: "White Cross Vets has an unrivalled reputation for offering exceptional pet care, as well as being recognised as a great place to work, which really appealed to me. To become the group’s 200th employee is fantastic and I’m really looking forward to the opportunities and challenges that lie ahead."
Tim Harrison, Managing Director of White Cross Vets, said: "Welcoming 50 new team members into the White Cross family in the last 12 months is a major coup and we’re delighted to have created a 200 strong team with Eilona’s appointment. We are already planning to expand our team further over the coming months, with three new practices due to open before the end of this year, which makes it a very exciting time for us."
Vétoquinol has announced plans to raise £10,000 for The Blue Cross pet charity through sales of Propalin, its fast acting treatment for incontinence in dogs.
From 1st July to 31st December this year, for every 100ml bottle of Propalin ordered, Vétoquinol will give 18p to The Blue Cross and 7p for every 30ml bottle.
To boost the amount raised for The Blue Cross, Vétoquinol is offering vets a free bottle of Propalin for every six bottles ordered of both the 100ml and 30ml sizes.
For example, if you order 18 100ml bottles of Propalin, you will receive 6 free bottles and The Blue Cross will receive £4.32.
Vanessa Rossiter, corporate fundraising officer for The Blue Cross said: “As a charity, The Blue Cross relies on donations to support our adoption centres and animal hospitals around the country. We are very grateful to Vétoquinol for their pledge to raise funds for the hundreds of needy animals in our care.”
According to Vétoquinol, Propalin is the UK’s best selling licensed veterinary treatment for urinary incontinence in the ***. It contains phenylpropanolamine hydrochloride, which acts to increase the tone in muscles that make up the urethal sphincter. It takes effect within 30 minutes of administration and, as a liquid, is highly palatable.
The Disciplinary Committee of the Royal College of Veterinary Surgeons last week decided that a Lincolnshire-based veterinary surgeon should not be restored to the RCVS Register, having previously struck him off for disgraceful professional conduct, as it was not convinced that he accepted the seriousness of its finding.
In October 2007, Robert Morris, of Brant Broughton, near Lincoln, was removed from the Register having been found guilty of falsely certifying a horse to be fit for sale, despite knowing that it had a respiratory problem that could prejudice its use in the future by its new owners.
At the hearing, which concluded on 7 January, the Disciplinary Committee focused on several areas. On the day following the Committee's decision in October 2007, Mr Morris had falsely certified that two horses had been fully vaccinated every six months by his practice, when he did not know that this was the case. On two occasions during September and October of 2009, he had held himself out to be a veterinary surgeon, including examining, diagnosing and treating animals (horses and dogs). These issues, together with the fact that Mr Morris told the Committee that he was not fully familiar with the Twelve Principles of Certification, as set out in the RCVS Guide to Professional Conduct, led the Committee to believe that Mr Morris did not understand the seriousness of his conviction for disgraceful professional conduct.
The Committee also felt that there was a risk to future welfare of animals and protection of the public arising from Mr Morris' failure to understand the importance of certification. That he remained unfamiliar with the veterinary medicines regulations (and had been convicted at Grantham Magistrates Court on 1 November 2007 for possession of unauthorised veterinary medicinal products on 7 March 2006), was also taken as relevant in this regard.
The Committee also took into account the fact that Mr Morris had undertaken only limited continuing professional development since his removal, and it was concerned that it had not been presented with sufficient evidence to confirm Mr Morris' assertion that he no longer suffers from an alcohol problem.
Chairing the Disciplinary Committee, Mrs Alison Bruce, said: "In the light of its finding that Mr Morris does not fully understand the importance of accurate certification, nor of practising as a veterinary surgeon when he was not entitled to do so, the Committee considers that there is a risk to the future welfare of animals in the event of his name being restored to the Register."
She went on to add that in the case of veterinary surgeons continuing to work in a practice when struck off: "It is fully appreciated that veterinary practices may be owned and managed by lay people, however there must be a clear distinction between managing or working within a veterinary practice and practising veterinary medicine. It is of particular importance that any member who has been removed should recognise the difference between these activities. A member who has been removed must refrain from examining animals, making diagnoses or performing treatments, even under the direction of another veterinary surgeon, this includes giving veterinary advice."
Grahame Gardner Ltd has announced the launch of a classically styled tunic, the M559, now stocked in bottle green for the first time.
The company says that although there have been numerous ladies tunics available in bottle green, this is the first time Grahame Gardner has stocked a male tunic in the characteristic veterinary colour.
The contemporary design of the M559 incorporates side fastening with the option of contrasting epaulettes, alongside practical pockets and side slits. According to the company, it's a tunic that looks great and performs exceptionally well in the veterinary practice. Stocked in sizes from 34" to 50" (chest), the M559 is one of several new styles introduced within Grahame Gardner's latest 124 page brochure.
To explore Grahame Gardner's collection please take a look at http://www.grahamegardner.co.uk/, or call 0116 255 6326 to order a copy of the new brochure.
The publicly supported Dog Control Bill moves a step closer towards changing dangerous dog legislation for good as it reaches Report Stage in the House of Lords today.
Over 10,000 people signed up to support it and animal welfare organisations and charities throughout the UK are backing it; Lord Redesdale's Dog Control Bill would replace the widely criticised Dangerous Dogs Act (1991), by targeting the inappropriate behaviour of any dog, and more importantly the owners of such dogs, to reduce the occurrence of serious dog incidents, rather than continuing to demonise specific breeds or types.
The Bill is championed by the Dangerous Dogs Act Study Group (DDASG), a wide-ranging group representing animal welfare, local authorities and veterinary professional organisations who have been actively involved in resolving the inadequacies of the current 'dangerous dog' legislation for many years.
The DDASG considers that the Dangerous Dogs Act needs to be overhauled to better protect the public and that a new dog control regime which emphasises responsible dog ownership should be introduced.
DDASG Chairman Chris Laurence said: "We have had considerable input into the Dog Control Bill and are confident that the Bill takes huge steps towards changing the manner in which owners of dogs that are out of control will be dealt with; the emphasis being on the prevention of dog bites."
The Report Stage of the Dog Control Bill is listed as the first item of business in the House of Lords on this morning and comes as Defra's public consultation on dangerous dogs shows further support for this approach with 71% of respondents calling for breed specific legislation to be repealed.
In support of the Bill, the DDASG launched a petition which has received over 10,000 signatures. The petition can be found at http://www.gopetition.com/petitions/repeal-and-replace-the-dangerous-dogs-act.html. The DDASG has also been working with other major stakeholders including the Royal Society for the Prevention of Cruelty to Animals and will be issuing a joint briefing to government tomorrow, entitled 'Finding solutions to irresponsible dog ownership' which outlines where urgent action must be taken in existing dog legislation to improve huge inadequacies within the law.
Subject to the Bill passing the Report Stage, the Third Reading will take place after summer recess before moving to the House of Commons for further consideration. For more information on the DDASG, Lord Redesdale's Dog Control Bill and current legislation, visit http://www.thekennelclub.org.uk/item/928.
The European Commission has agreed with the BSAVA and BVA that controls must be maintained to keep the UK free from the tapeworm Echinococcus multilocularis, and adopted a regulation that will permit pre-movement treatment for dogs travelling to listed Member States (i.e. the UK, Ireland, Finland and Malta).
In June Defra announced that the UK's derogation from European pet travel rules, which allows additional protection for the UK against rabies, ticks and tapeworms, would end on 31 December 2011. The movement rules on rabies and ticks will now be harmonised with the rest of Europe.
However, due to the significant public health risk posed by Echinococcus multilocularis, the BVA and BSAVA (working with Defra, the Federation of Veterinarians of Europe [FVE] and colleagues in Veterinary Ireland) continued to lobby the European Commission for controls on tapeworms to be maintained.
The regulation will ensure that a dog must be treated by a veterinary surgeon 24 to 120 hours (1-5 days) before entering one of the listed countries.
The BVA and BSAVA say they made a scientific case for a treatment window of 24-48 hours, but accept that the Commission had to find a compromise that would assist pet owners travelling during national holidays.
Harvey Locke, President of the BVA said: "This has been a long process but the BVA and BSAVA put forward the strong scientific case for the UK to maintain tapeworm controls and we are delighted that the European Commission has adopted this resolution.
"In our role as guardians of public health, vets were deeply concerned that the removal of tapeworm controls would see the introduction of EM to the UK and Ireland.
"Although relatively benign in dogs, the resulting disease in humans - alveolar echinococcosis - is an invasive, cancer-like cystic stage of the parasite, and is invariably fatal if not treated.
"The next stage of our lobbying will be to ensure that Member States and MEPs from across Europe support the UK's case for the additional controls."
Andrew Ash, President of BSAVA said: "Echinococcus multilocularis is a significant public health threat and we have worked hard to ensure the European Commission understands the potential impact of allowing this zoonotic disease to enter our country.
"The BVA and BSAVA will continue to promote the best possible health and welfare advice for pet owners taking their animals abroad. Our advice to owners is to speak to a vet as early as possible to make sure pets are protected from all diseases and parasites encountered abroad."
The Westpoint Group has announced the divestiture of its small animal and equine veterinary practices in order to focus on production animal health and welfare.
From now, the production animal business - which includes veterinary practices providing services to pig, poultry, dairy, beef, sheep, game bird producers and small holders - will be known under the umbrella brand of Origin.
The company says that excellence and innovation in client service will continue to be the focus throughout the organisation.
Matt Dobbs, Managing Director of Origin said: "Origin is committed to supporting livestock farmers to enhance production by improving health and welfare. We have a unique group of vets, researchers, lab techs and paraprofessionals passionate about the success of UK agriculture, with other businesses committed to supporting the industry, joining us through the autumn.
"By focusing on supporting farmers, we will become a unique source of animal insight in livestock agriculture."
For more information, visit: http://www.westpointveterinarygroup.com
Modules for the first GPAdvCert – in Small Animal Orthopaedics – will begin in February 2018. Improve says it's the first of many 'next steps' programmes which it plans to launch under this new postgraduate level qualification.
The GPAdvCert in Small Animal Orthopaedics is aimed at veterinary surgeons who have completed their General Practitioner Certificate in Small Animal Surgery (GPCert SAS) or Postgraduate Certificate (PgC) in Small Animal Surgery.
Accredited by the European School of Veterinary Postgraduate Studies (ESVPS) and validated by Harper Adams University, the programme is delivered over 15 modules in three state-of-the-art European training centres - Sheffield, UK, Cremona, Italy and Madrid, Spain. Improve says delegates will learn from world-class clinicians and will be supervised in their practise of new surgical techniques and advanced procedures in a wet-lab environment.
David Babington MRCVS, Managing Director of Improve International (pictured right), said: "We felt there was a gap in the current structure for a postgraduate qualification which would allow students to advance their knowledge and practical skills in their chosen area and to add to their academic credentials. The General Practitioner Advanced Certificate is our solution."
Successful achievement of the GPAdvCert will enable delegates to progress from a Postgraduate Certificate in Small Animal Surgery (or equivalent) to the Postgraduate Diploma in Advanced Veterinary Practice Sciences in the UK, which is awarded by Harper Adams University. This can, in turn, be used towards the award of a Masters Degree (MSc) in Advanced Veterinary Practice Sciences.
David added: "Delegates for our first GPAdvCert in Orthopaedics for Small Animals will enhance their skills and confidence in dealing with more advanced orthopaedic procedures in-house and this will help them to reduce the number of patients which are referred, retaining a higher level of income for their practice. They will also develop skills which they can pass onto their team. We look forward to welcoming our first delegates next year."
Further details are available at: https://www.improveinternational.com/uk/course/general-practitioner-advanced-certificate-in-small-animal-orthopaedic-surgery/
The materials are designed to help educate pet owners on the benefits of microchipping and the importance of keeping their microchip details up to date.
The company highlights research which shows just how important it is to encourage owners to keep microchip details up to date. In 2017, the BVA found that 44% of vets were unable to reunite stray dogs with their owners due to incorrect information on the microchip database. The Dogs Trust Stray Dogs Survey Report 2017–18 also found that 75% of all microchipped dogs that were unable to be returned to their owners had incorrect contact information on their chip.
To order your 'Chip & Check' display, contact your Animalcare Territory Sales Manager, or call Animalcare's head office on 01904 487687. Display packs are subject to an order of identichip microchips and while display stocks last.
The new guidance replaces Chapter 25 of the Supporting Guidance to the Code of Professional Conduct.
Routine Veterinary Practice describes the procedures and techniques performed on animals by veterinary surgeons (or veterinary nurses under their direction) in the course of their professional duties, which ensure the health and welfare of animals committed to their care.
CVR is when routine procedures are undertaken for the benefit of the animal/s, with the concurrent intention to generate new knowledge that benefits animals, such as developing new procedures, improving a diagnosis, changing a routine procedure, or comparing existing procedures.
While the idea of CVR is not new, this is the first time that the RCVS has provided specific guidance on it.
The guidance also introduces an obligation, which comes into effect on 1st September, to obtain ethics review for all studies where one would be expected to obtain permission from the owner/keeper of an animal prior to being enrolled, or when consent is needed for use of previously collected samples or the use of data from an animal.
The newly drafted Chapter 25 gives extra guidance on the following areas:
Chair of the Standards Committee and incoming RCVS President, Dr Melissa Donald (pictured right), said: “We hope that the guidance will inspire confidence in our veterinary colleagues at all levels to undertake treatment routes which develop veterinary knowledge as a whole, while still being for the benefit of the animal being treated.”
For further information or advice on whether a proposed procedure would be covered by the guidance, contact the Standards and Advice team via advice@rcvs.org.uk.
The new guidance will be found on the RCVS website from the 1st July: www.rcvs.org.uk/recognised
For further information in relation to ethics review of proposed veterinary clinical research studies, contact the Secretary to the RCVS Ethics Review Panel via ethics@rcvs.org.uk or visit www.rcvs.org.uk/ethics
With recruitment and retention issues in many sectors of the profession, the Association says flexible working might improve job satisfaction and therefore retention.
Other statistics from the survey showed that whilst levels of flexible working have risen from 44% in 2019 to 50% in 2021, 36% of those who already work flexibly 36% would like more flexibility.
The most common reasons vets gave for wanting to work more flexibly were: to allow more time for leisure activities (56%), lifestyle needs (50%), caregiving responsibilities (28%), health reasons (28%), for professional development (22%) and for voluntary work (16%).
The type of flexibility vets were hoping to achieve also varied. Working part time was the most common type of flexible working sought (31%), followed by homeworking (16%), flexitime (13%) and compressed hours (5%).
As part of its campaign, the BVA has launched "Flexible working: Embracing flexibility in the veterinary profession", a booklet which includes facts, figures and case studies to help demonstrate how flexible working can benefit both employers and employees in a range of different veterinary teams.
The booklet also offers tips and advice on tackling some of the challenges that can arise when introducing increased flexibility into a clinical workplace.
BVA Junior Vice President Malcolm Morley said: “The statistics clearly show that there is a huge appetite for more flexibility in working hours, particularly in clinical practice, where employers have previously been quite hesitant to explore this option.
"We understand that there are potential challenges to allowing more flexibility but we’re hoping to demonstrate that these are not insurmountable.
“It’s vital that the profession recognises that inflexible working patterns contribute to poor retention—recognition is the first stage in finding a solution.
"Embracing developments in flexible working could increase job satisfaction for many team members and ultimately improve retention.”
Malcolm added: “The profession continues to face serious staffing shortages and we understand that the increased pressures on vet teams may make some employers anxious about introducing flexible working at a time when they are already struggling to cover shifts.
"However, the solution does not lie with vet teams working increasingly longer hours; a successful solution will need team members to be involved in supporting each other’s working patterns.
"Promoting a better balance between home and work could be key to supporting many staff who are currently unsure about remaining in the profession or returning to work."
www.bva.co.uk/flexible-working
Petplan is running its television advertising campaign from now until October.
The advert (below) is airing on Sky 1, Sky Atlantic, ITV2, ITV3, More 4, Gold and USA.
Suzanne Cheadle, Acting Head of Marketing at Petplan said: "As the UK market leader, it is imperative that pet owners recognise and understand who we are and what we stand for. We need to help pet owners understand not only why pet insurance is so important, but explain why they should choose Petplan over any other provider. In 36 years, there's not an illness or accident that we haven't seen, and our Covered For Life policies have been developed with unrivalled knowledge and experience."
The HT Vista device measures heat transfer rate differences between masses and adjacent normal tissues and then processes that data using machine learning algorithms to classify the masses.
The study evaluated a diverse canine population of 299 dogs with 525 cutaneous and subcutaneous masses.
In the study, the device correctly classified 45 out of 53 malignant masses and 253 out of 378 benign masses (sensitivity = 85% and specificity = 67%).
The negative predictive value of the system (i.e., percent of benign masses identified as benign) was 97%.
This study concluded that the data supports the use of the HT Vista device "as a screening tool and decision support tool for the everyday diagnosis of dermal and subcutaneous masses in general practice, enabling clinicians to differentiate between benign lesions and those requiring additional diagnostics".
Liron Levy-Hirsch, Managing Director of HT Vista’s UK subsidiary said: “We are thrilled to have scientific research validating the success of the HT Vista device.
"The veterinary teams who have already adopted the device into their practice are having great success with it, and with the backing of this newly published paper we hope to reach more practices and ultimately save more dog’s lives.”
www.ht-vet.com / www.ht-vista.uk
Reference
Bayer Animal Health, maker of Advocate and organiser of the Be Lungworm Aware campaign, is warning that last year's damp summer and the mild winter conditions may lead to a continued spread of Angiostongylus vasorum in the UK.
Biodiversity & Conservation Officer for The Natural History Museum, Professor Fred Naggs, said: "An increase in the number of slug and snail populations this year would suggest there will consequently be a continued spread of the parasite. However, this depends on a number of factors: (i) the number of slugs and snails around last year, of which there were many (ii) the level of precipitation throughout the year, as slugs and snails will breed continuously when temperatures are mild to warm and there is adequate relative humidity. According to many reports in the press, last year was one of the wettest on record (iii) the survival of slugs and snails over the winter. As this winter has not been particularly harsh, reasonable numbers of slugs and snails should have survived."
In addition, a study by the RVC as shown that A. vasorum is spreading beyond the traditional geographic distribution with 20 per cent of veterinary practices across the country reporting at least one case of A. vasorum. 1
To help raise awareness of the parasite, veterinary surgeons and nurses are being encouraged to support the 'Be Lungworm Aware' campaign. The scheme will offer support and education to owners and participating vet practices throughout this month, which has been labelled 'Lungworm Awareness Month'.
Caroline Braidwood, Group Product Manager at Bayer Animal Health said: "While dog owners are becoming more aware of A. vasorum, there is still a real lack of understanding as to the warning signs associated with the condition and how to prevent or treat it. Some owners still believe that Lungworm can be prevented by using normal intestinal wormers which is not the case - Advocate is the only product that can prevent A. vasorum, and from the first application. Our aim with the 'Be Lungworm Aware' campaign is to drive pet owners to their vet practice, where they can then be informed of the danger of the parasite and educated about correct preventative treatment."
Practices can request a range of materials including a practice press pack by calling their Bayer Territory Manager. The pack is designed to promote the awareness campaign to local dog owning clients and includes a regional press release, images and other collateral including leaflets, posters and a campaign DVD for display in waiting rooms.
For more information on lungworm, visit www.lungworm.co.uk
1. Royal Veterinary College survey 2012, 1,419 veterinary practices
For practices planning to take part in National Microchipping Month, Virbac is providing a personalised poster design service and chip promotion throughout June.
According to product manager Gillian Brown, the idea is to offer additional tailored support to practices during the promotional period: "Obviously many practices will have National Microchipping Month materials in place, but the price each practice offers their clients is individual to them. These posters provide a visual platform to highlight the promotion.
"To take advantage of the scheme, practices just need to notify their territory manager of the price they propose to charge and we will then manage the design and print."
Virbac will also be offering a promotional chip price in June to support National Microchipping Month. Gillian said: "Microchipping is now the official means of pet identification approved by the EU Pet Passport Scheme. This will help practices provide an attractive promotion to pet owners and hopefully encourage greater up-take of microchipping."
Any practice interested in the initiative should contact their local Virbac territory manager or call Virbac on 01379 243243.
Vetoquinol - makers of the NSAID Cimalgex - has announced the launch of its updated website www.CiMyDog.co.uk.
The company says the website has been developed to provide reliable online information about pain in dogs to cater for the increasing needs of pet owners and vets.
The website has two sections. The first is a pet owner focussed, educational tool which takes the visitor on a journey through the process of pain; from spotting the signs of pain all the way through to ways of relieving pain, culminating in the recommendation that the visitor seeks advice from their veterinary practice.
The second section requires registration as it contains more in depth information on the pain process and potential treatment options available, this section is for veterinary professionals only. Also on this section of the website there are many scientific abstracts related to pain and treatment with links to enable the veterinary visitor can view this peer reviewed material.
Robert Simpson, Cimalgex Product Manager said: "The internet is a very powerful tool in terms of increasing education, especially in areas such as canine pain. Unfortunately there can also be a lot of misinformation online and so we felt it was important for Vetoquinol to try and redress the balance by producing www.CiMyDog.co.uk. This can be used as a reliable and up-to-date resource by pet owners and veterinary professionals alike. -
www.CiMyDog.co.uk is a very interactive site which aims to demystify the pain treatment process, ensure pet owners look out for behavioural signs of pain and looks to improve overall canine health with assistance from their veterinary practice. We hope that this will be a valuable resource to which vets can refer their pet owners."
Three veterinary surgeons and an appointed RCVS Councillor have been awarded an OBE in the Queen's Birthday Honours.
Caroline Freedman, who has been appointed to Council from the University of Edinburgh since 2005, received a British Empire Medal for services to animal welfare in Edinburgh. Caroline will be officially retiring from Council at RCVS Day on Friday 11 July but will remain as a lay member of the Practice Standards Group - the coordinating body for the Practice Standards Scheme.
Three veterinary surgeons were also awarded OBEs in the Queen's Birthday Honours. Sarah Cleaveland, Professor of Comparative Epidemiology at the University of Glasgow, was honoured for her contribution to veterinary epidemiology. Robert Houston, former Chief Veterinary Officer for Northern Ireland, was recognised for services to veterinary science in the country and Professor Julie Fitzpatrick, the Scientific Director of the Moredun Research Institute and Chief Executive of the Moredun Foundation, was honoured for services to animal health and science.
RCVS President Colonel Neil Smith said: "I am delighted to see these very deserving people from the veterinary world receive their due recognition in this year's Birthday Honours.
"During her time on Council Caroline has provided a greatly valued lay perspective on the veterinary issues of the day and I am pleased that she will continue to give her valuable insight to the organisation through the Practice Standards Group.
"Professor Cleaveland is our guest speaker at this year's RCVS Day where she will be speaking about her vital work in tackling zoonotic diseases on an international basis, so I am delighted to see that her contribution to human and animal health is being recognised.
"In addition, Bert Houston and Professor Fitzpatrick have contributed a great deal to both the veterinary profession and animal welfare in UK, with the latter being a member of our former Research Subcommittee."
The company points to an increasing trend across Europe towards feeding raw diets to pets, with 4% of UK cats and 10% of UK dogs now being fed raw meat and animal by-products.
The webinar, which will also look at the role of testing, offers an opportunity to learn more about the pathogens and parasites associated with raw feeding and the role of the right test at the right time.
Horiba says it's not just pets that need testing, but the raw materials used in their food.
Ian, who is Head of ESCCAP (the European Scientific Council for Companion Animal Parasites) UK & Ireland, said: “The recent trend of increasing raw feeding opens up new opportunities for pathogen transmission.
"Where raw feeding is taking place, adequate tapeworm and protozoal parasite prevention is essential to reduce zoonotic risk and economic losses.
“Testing forms an essential part of their control, and understanding this role and the diagnostic test options available will prove valuable to all veterinary professionals.”
Following Ian's presentation, there will be an open Q&A session.
Horiba’s team of veterinary specialists will also be available at the end of the webinar to discuss and advise on any testing needs, including its veterinary PCR system, the POCKIT Central.
To register, visit: https://register.gotowebinar.com/register/4306408134214190348
The dispensation was originally introduced during the spring 2020 lockdown to safeguard animal health and welfare, the health and safety of the veterinary team, and public health, by allowing prescriptions to be made by veterinary surgeons without their having first physically examined the animal, subject to conditions and safeguards.
The RCVS says the Committee considered the ongoing challenges posed by Covid-19 and recognised that staff absences due to isolation requirements were still causing issues.
However, given the relaxation of the requirement to work from home in England, Scotland and Northern Ireland and relaxation of restrictions generally across the UK, the Committee felt it was time to end the dispensation.
Chair of the Standards Committee, Dr Melissa Donald MRCVS, said: “The safety and wellbeing of veterinary professionals, as well as the health and welfare of the animals they care for, have remained uppermost in our minds when considering this temporary position on remote prescribing.
“We are pleased to have been able to support the professions through a very difficult time by introducing this dispensation, however, it was only ever a temporary measure and, given the relaxation of restrictions across the UK, we feel the time has come to revert to our usual guidance.
“We will continue to keep the position under review in light of any changes, including governments’ advice and regulations, as we have throughout the pandemic.”
They say that they've been aware of minor interruptions to the supply of such vaccines throughout 2022.
However, a significant, pan-European logistical problem being experienced by Boehringer Ingelheim has raised the prospect of a further reduction in supplies in the coming months.
BEVA is liaising with the three vaccine manufacturers to quantify the impact of the shortage and to consider solutions, both to minimise the threat to equine health and to prevent disruption to equestrian competition.
Marc Laemmer, equine business head at Boehringer Ingelheim Animal Health, said: “We are currently experiencing a European-wide supply issue relating to our equine influenza and influenza-tetanus vaccines.
"This has been caused by unexpected issues following the implementation of a technology upgrade and is not a product or quality issue.
"This means that some vet practices will have difficulty obtaining sufficient influenza vaccines and there may be a shortage in the UK market.
"We understand the importance of these vaccines to equine welfare, and we are continuing to work tirelessly to find a solution so that we can return to normal supply as soon as possible.”
Amanda Melvin, equine business manager at MSD Animal Health, said: “Based on prior demand, MSD’s equine vaccines Equilis Prequenza and Equilis Prequenza Te are in full supply.
"MSD have taken steps to protect as many horses as possible at this time.
"We will continue to supply existing customers with the available MSD stock on ‘allocation’ and, where possible, to allocate stock to additional customers. Allocations are being made to our veterinary customers based on their historical demand which we believe is the most efficient way to manage the available supplies.”
Rebecca Cabrejas, equine business unit manager at Zoetis, said: “Demand for our vaccines currently exceeds what we can supply.
"Whilst we have adequate stocks to fulfil current customers’ orders unfortunately, we are not in a position to be able to supply new customers at this time.
"We will continue to work with BEVA to limit the impact of the current shortages.”
Over half way through Intervet's National Vaccination Month, and according to the company, over 2100 practices are taking part.
Various statistics the company has released, which you might find interesting:
Nearly two thirds of all vet practices have seen parvovirus, in the past year, while 43% have seen leptospirosis, which is spread by rats.
62% of pet owners consider their animal to be an extremely important member of the family with over half (58%) buying them Christmas presents and over one in four (27%) taking time off work for their pet.
However, only 56% of these pets were vaccinated and around more than quarter (28%) of owners were unaware of any disease risk.
Currently, 3 million dogs, 6 million cats and 1.8 million rabbits are unvaccinated, leaving them at risk of a range of fatal diseases, many of which are untreatable.
Intervet has put together an impressive range of support materials for National Vaccination Month, including a pet-owner website: http://www.vaccinationmonth.co.uk/, a discount voucher scheme (on the website) for use in participating practices, TV advertising and a Vaccination Month Podcast primarily aimed at owners.
A new expert panel has been formed to evaluate pain management in canine osteoarthritis following a recent shift to a more integrated approach to pain and disease research.
In the past, pain and joint disease have been considered as separate areas of research, with pain perceived simply as a consequence of disease. Over the last few years, however, it has become increasingly apparent that the relationship is far more complex and that pain may be a driver of disease rather than just a consequence of it. The expert panel hopes to apply the new knowledge to the management of joint pain in veterinary practice.
The panel, which had its inaugural meeting in Paris recently, brings together acknowledged veterinary experts in the fields of pain and joint disease. Its focus will be on the assessment and management of pain in canine osteoarthritis (OA), with the objective of educating veterinary surgeons to better understand and manage pain in canine OA and thereby improve the well-being of pets that suffer from this common disease.
'Central sensitisation' is one of the latest theories that has been suggested to explain the complex interaction between pain and disease progression in canine OA. Duncan Lascelles, Associate Professor of Surgery at North Carolina State University, said that research has shown that the components of the pain pathway can change in response to a pain stimulus. Pain receptors 'up-regulate' in response to painful stimuli and become more sensitive to subsequent pain.
CNS sensitisation is likely a significant contributor to chronic or maladaptive pain; this pain leads to decreased mobility, reduced muscle support and reduced muscle function, thus leading to disease progression. In other words, joint diseases cause pain, which in turn feeds back to create more disease.
Professor Lascelles said: "The link between the clinical signs associated with OA and joint pathology is not a simple one and may be much more complex than we have previously thought.
"There is some evidence that COX inhibition reduces central sensitisation. And some evidence suggests that reducing central sensitisation may have a modulatory effect on disease progression by reducing signals going out to the periphery.
"The relationship between pain and disease progression is a very new area of research, and is at the forefront of our knowledge of how pain and joint disease are linked."
Professor John Innes, Head of Division, Small Animal Studies, University of Liverpool Veterinary School, told the meeting that OA is likely to be one of the major reasons for euthanasia of pet dogs in Europe. He and two co-investigators have performed a systematic review of the published evidence for the use of long-term, continuous NSAID treatment (at least 28 days) in OA. They found that this form of management is associated with better outcomes than short-term NSAID therapy, with no evidence of additional safety issues. This review is to be published shortly.
The expert panel comprises:
Prof Dr Stuart Carmichael, Vets Now Ltd. Formerly at: Veterinary School, University of Glasgow, UKProf Dr John Innes, Small Animal Teaching Hospital, University of Liverpool, UKDr Bernard Bouvy-Centre, Hospitalier Vétérinaire de Frégis, Arcueil, FranceProf Dr Jean-Pierre Genevois, Ecole Nationale Vétérinaire de Lyon, FranceDr Carlos Macías, Centro Veterinario de Referencia Bahia de Malaga, SpainProf Dr Martin Kramer, Klinik für Kleintiere, Chirurgie , Justus-Liebig-Universität Gießen, GermanyDr Sabine Tacke, Klinik für Kleintiere, Chirurgie, Justus-Liebig-Universität GießenProf Dr Duncan Lascelles, North Carolina State University College of Veterinary Medicine, Raleigh, USAProf Dr Herman A.W. Hazewinkel, Faculteit Diergeneeskunde, Departement Gezelschapsdieren, Utrecht, NetherlandsDr Emilio Feltri, Anaesthetist and specialist in Pain Management, Ambulatorio Veterinario Associato, Tortona, ItalyDr Peter Vandekerckhove, Specialist Surgeon Companion Animal, Wondelgem, Belgium
VetIT is launching a new suite of practice management software this month, which it claims will wipe out IT support worries while also giving vets secure access to their records wherever there's an internet connection.
Designed for practice-based and mobile vets, its developer says the near-universal access of the system will make VetIT ideal for the progressive and forward-thinking veterinary practice, particularly those with multiple locations. Early clients are already seeing the benefits of the system, which has been four years in development.
VetIT's Tony Houghton said: "The software offers practices a host of new features, all of them designed to increase usability, enhance revenue, reduce running costs and eliminate IT concerns. And because the new system has been developed in partnership with a well-established veterinary practice, VetIT sees and does things from a vet's perspective.
"During the development phase, our practice partner told us that existing packages were unwieldy - whether in their day-to-day operation, the ability to see and share data, or the 'back office' administration required. So we designed VetIT from scratch, to work in the most user-friendly manner."
According to Mr Houghton, the most significant difference is in how the software works - and in recognising that most practices expect IT systems to 'happen' in the background, rather than devouring precious time. "Existing packages are physically located in your practice - usually on a dedicated server, requiring daily back-ups and maintenance.
"VetIT, conversely, is a 'web-hosted solution' - like Sage Online or for that matter, Facebook - which means it's accessible to users wherever there's a browser and an internet connection: main or branch practice, home or out in the field. Log in from anywhere and you'll always see the same data.
"Practice data is held securely at a remote location and, with automatic back-up systems, some of the biggest worries about onsite IT systems - theft, fire, flooding and protection from computer viruses - are removed immediately.
"In the event of system maintenance or issues, customers talk to a friendly, UK-based support and development team, who can access and modify the system in real time; practices won't have to wait for an engineer to attend. In fact, we have a very content practice in Oman now running the system; the installation and set-up has all been carried out from a distance."
By removing the 'IT headache', Mr Houghton says practices choosing VetIT will be able to run their businesses more effectively, while developing closer, more valuable relationships with customers.
He said: "The web-based system allows vets' customers to log-in to 'their' VetIT, where they can check records, pay bills, or place orders. Practices can also maintain and build a relationship with customers via e-mail and SMS reminders of appointments, check-ups, treatments due and so on."
As for running costs and pricing, Mr Houghton cites pre-launch studies showing the potential for productivity gains in practices deploying VetIT, while the system's clear pricing - from low-cost start-up practices to corporate licensing for multi-site operations - gives peace of mind with smooth, predictable costs through the system's life. "You don't have to buy expensive computer hardware like servers and back-up systems, and pay-as-you-go pricing eliminates up-front software licensing costs."
Mr Houghton says users in so-called 'notspots' - areas of the country where broadband connections run at less than 2Mbps or are non-existent - need not feel left out, either. "We've designed the system to be as fast as possible, with no heavy data-transfer requirements. In fact, data transfer within the system is so well optimised that it will even work with a dial-up connection or mobile broadband."
More information about VetIT is at http://www.vetit.co.uk/, or contact Nick Cole.
In June the College held a six-week consultation with the profession, asking for opinions on its proposal for an outcomes-based approach to CPD which would concentrate less on hours logged and more on interactive, reflective learning and measuring the impact that CPD has on the individual’s practice and patient health outcomes.
The proposed model for CPD had four key components: planning, doing, recording and reflecting. While an overall majority of the 3,357 people who responded to the College’s consultation agreed with the proposed changes to the CPD requirement, certain elements received less support than others. The lowest amount of support was received for the ‘reflection’ component with 35% of respondents disagreeing with it.
The RCVS Education Committee therefore decided that a pilot of a new outcomes-based approach should be held during 2017 with a group of volunteers, before making a recommendation to Council.
Professor Stephen May, who chaired the Working Group that developed the CPD proposals, said: "Because of the concern voiced by members of the profession responding to the consultation we decided that, at this stage, it would not be appropriate for the RCVS to move straight into this new way of doing CPD but that it would be more appropriate to hold a pilot. The idea is that we will explore some of the concerns around reflection and around the extra time and paperwork that people felt that a more reflective approach may lead to.
"We have taken all these comments into account and are now seeking to work with individual volunteers on this pilot. It is important to note that we are not only looking for volunteers who agree with what we are doing but also those who are apprehensive about it or even some who see it as something they do not support. We want to explore the full range of views and how we can move forward in changing our approach to CPD."
The pilot is expected to be launched in February next year and the College is now looking for volunteers who both support the proposals and have a ‘healthy scepticism’ about them. Volunteers will receive help and support throughout the trial and will also be invited to attend an introductory CPD meeting at the RCVS offices in February.
If you are interested in volunteering, contact Jenny Soreskog-Turp, RCVS CPD Officer, on cpd@rcvs.org.uk.
Further information, including the CPD Policy Working Party’s response to the consultation and the full interview with Stephen May, is available at www.rcvs.org.uk/CPDpilot.